Document is current
Any future updates will be listed below
-
Authors
Okamoto, Jeffrey https://orcid.org/0000-0001-9988-1618
Yin, Xianyong
Ryan, Brady
Chiou, Joshua
Luca, Francesca
Pique-Regi, Roger
Im, Hae Kyung
Morrison, Jean
Burant, Charles
Fauman, Eric B.
Laakso, Markku
Boehnke, Michael
Wen, Xiaoquan
-
Funding
Funding for this research was provided by:
National Institutes of Health (NIH-R01-ES033634)
National Institutes of Health (NIH-R35-GM138121)
National Institutes of Health (NIH-R01-DK062370)
National Institutes of Health (NIH-R01-HL162574)
National Institutes of Health (NIH-R01-GM109215)
National Institutes of Health (NIH-R01-GM109215)
National Institutes of Health (NIH-R01-HL162574)
National Institutes of Health (NIH-R01-ES033634)
National Institutes of Health (NIH-R01-ES033634)
- License Information
-
More Information
Article History
Received: 6 February 2024
Accepted: 21 January 2025
First Online: 3 February 2025
Declarations
:
: The review history is available as Additional file 2.
: Tim Sands was the primary editor of this article and managed its editorial process and peer review in collaboration with the rest of the editorial team.
: Not applicable.
: Not applicable.
: EBF and JC are employees and stockholders of Pfizer. The remaining authors declare no competing interests.
